Pharmaceutical manufacturing with a focus on Cardiology and CNS therapies in India.
Annual revenue $181,447 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Wytech Pharmaceuticals

Wytech Pharmaceuticals is a company. Wytech Pharmaceuticals offers products and services including Nitrojet and Rozunice.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $181.45 K (USD)
    -14.1
    as on Mar 31, 2021
  • Net Profit
    $3.7 K (USD)
    -24.24
    as on Mar 31, 2021
  • EBITDA
    $7.25 K (USD)
    172.98
    as on Mar 31, 2021
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Wytech Pharmaceuticals

Wytech Pharmaceuticals offers a comprehensive portfolio of products and services, including Nitrojet and Rozunice.

Product name locked
Category locked
Primary

Nitrojet is offered for cardiovascular treatments, with manufacturing processes that ensure compliance with international standards.

Product name locked
Category locked
Locked

Rozunice is provided for central nervous system disorders, drawing on expertise from professionals with backgrounds in reputed companies.

Funding Insights of Wytech Pharmaceuticals

Premium access

Detailed funding history for Wytech Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Wytech Pharmaceuticals

Investments
Premium access

Investment portfolio details for Wytech Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Wytech Pharmaceuticals

Premium access

Detailed financials for Wytech Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Wytech Pharmaceuticals Comparisons

Wytech Pharmaceuticals Primary company
Description
Pharmaceutical manufacturing with a focus on Cardiology and ...
Location
-
Founded Year
-
Annual Revenue
$181.45 K (USD)
Net Profit
$3.7 K (USD)
EBITDA
$7.25 K (USD)
Employees
Not available
Premium access

Peer comparison for Wytech Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Wytech Pharmaceuticals

Premium access

Detailed competitors of Wytech Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Wytech Pharmaceuticals

Premium access

Complete news archive for Wytech Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Wytech Pharmaceuticals

Annual revenue of Wytech Pharmaceuticals is $181.45K as on Mar 31, 2021.

Wytech Pharmaceuticals Pvt. Ltd. is recognized for its operations in manufacturing pharmaceutical products, particularly in Cardiology and CNS areas, with products being produced in WHO GMP-certified plants to meet international standards. It is led by professionals who have gained experience from reputed Indian and multinational companies, emphasizing cost-effective pricing and partnerships with doctors, retailers, and wholesalers. Established in 2016, efforts are directed towards providing high-quality medicines at reasonable prices to address unmet medical needs globally, while upholding core values of knowledge, action, and care. An excellent team is employed to drive success in these therapies.

Wytech Pharmaceuticals offers Nitrojet and Rozunice.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available